Raiffeisen Bank International »

Ionis Pharmaceuticals shares owned by Raiffeisen Bank International

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Raiffeisen Bank International from 13F filings

Historical chart of Raiffeisen Bank International investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Raiffeisen Bank International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Raiffeisen Bank International

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 38k 72.52

More positions owned by Raiffeisen Bank International

Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOGL)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Amazoncom Common Stock (AMZN)
Applied Materials Common Stock (AMAT)
Eli Lilly & Co Common Stock (LLY)
Lam Research Corp Common Stock (LRCX)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Jpmorgan Chase & Co Common Stock (JPM)
Cisco Systems Common Stock (CSCO)
Abbvie Common Stock (ABBV)
Visa Common Stock (V)
Quanta Services Common Stock (PWR)
Advanced Micro Devices Common Stock (AMD)

View all positions for Raiffeisen Bank International

Top funds holding Ionis Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
T. Rowe Price Investment Management
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
Two Sigma Investments
State Street Corporation
Geode Capital Management
Royal Bank of Canada
Tweedy, Browne Company
Artisan Partners Limited Partnership
Baker Bros. Advisors

View all funds holding Ionis Pharmaceuticals